Not applicableStudy completedNCT04123678What this trial is testingDERM Health Economics StudyWho this might be right forMelanomaNon-melanoma Skin Cancer Skin Analytics Limited 700
Early research (Phase 1)Active Not RecruitingNCT05614102What this trial is testingA First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Bayer 284
Large-scale testing (Phase 3)UnknownNCT01088737What this trial is testingImiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo MalignaWho this might be right forLentigo Maligna Medical University of Graz 60
Testing effectiveness (Phase 2)Study completedNCT01009177What this trial is testingEffect of Bosentan in Patients With Metastatic Melanoma Treated With Dacarbazine (DTIC)Who this might be right forMelanoma Actelion 80
Testing effectiveness (Phase 2)WithdrawnNCT01851408What this trial is testingSorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaWho this might be right forMelanomaRecurrent MelanomaStage III Melanoma+1 more National Cancer Institute (NCI)
Post-approval studies (Phase 4)UnknownNCT03313544What this trial is testingEvolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1Who this might be right forMelanomaNon-small CellLung Cancer Assistance Publique Hopitaux De Marseille 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07339176What this trial is testingIntratumoral N17350 in Advanced Solid TumorsWho this might be right forNeoplasms, Solid TumorBreast Neoplasms, Triple-NegativeSquamous Cell Carcinoma of Skin+4 more Onchilles Pharma Inc 275
Early research (Phase 1)Study completedNCT03817125What this trial is testingMelanoma Checkpoint and Gut Microbiome Alteration With Microbiome InterventionWho this might be right forMetastatic Melanoma Parker Institute for Cancer Immunotherapy 14
Large-scale testing (Phase 3)Study completedNCT00769704What this trial is testingEfficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in MelanomaWho this might be right forMelanoma BioVex Limited 437
Not applicableLooking for participantsNCT07206017What this trial is testingExplorative Study on Addition of High-fiber Dried Chicory Root in Patients With an Intermediate to High-risk Cutaneous Melanoma.Who this might be right forMelanoma, Stage II University Medical Center Groningen 20
Early research (Phase 1)Looking for participantsNCT05859074What this trial is testingMQ710 With and Without Pembrolizumab in People With Solid Tumor CancerWho this might be right forCutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more Memorial Sloan Kettering Cancer Center 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT03999749What this trial is testingA Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV MelanomaWho this might be right forMelanoma NYU Langone Health 71
Testing effectiveness (Phase 2)Ended earlyNCT04157517What this trial is testingModakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid TumorsWho this might be right forNeoplasmsMelanoma Teva Branded Pharmaceutical Products R&D LLC 45
Testing effectiveness (Phase 2)Ended earlyNCT02062359What this trial is testingT Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing MelanomaWho this might be right forMetastatic CancerMetastatic Melanoma National Cancer Institute (NCI) 2
Testing effectiveness (Phase 2)Ended earlyNCT05219578What this trial is testingRTX-224 Monotherapy in Patients With Solid TumorsWho this might be right forNon Small Cell Lung CancerCutaneous MelanomaHead and Neck Squamous Cell Carcinoma+2 more Rubius Therapeutics 7
Testing effectiveness (Phase 2)Study completedNCT00135408What this trial is testingMDX-010 (BMS-734016) Administered With or Without Prophylactic Oral BudesonideWho this might be right forMalignant Melanoma Bristol-Myers Squibb 115
Not applicableStudy completedNCT00253708What this trial is testingMassage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic CancerWho this might be right forCancer Beth Israel Deaconess Medical Center 39
Not applicableStudy completedNCT03139513What this trial is testingAdult Participants With BRAF V600 Mutation-Positive Advanced Melanoma Treated With Cobimetinib (Cotellic®) During the French Early Access Program (Temporary Authorization for Use [TAU])Who this might be right forMelanoma Hoffmann-La Roche 200
Testing effectiveness (Phase 2)Study completedNCT02643303What this trial is testingTremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible CancersWho this might be right forHead and Neck Squamous Cell CarcinomaBreast CancerSarcoma+8 more Ludwig Institute for Cancer Research 58
Early research (Phase 1)UnknownNCT05103891What this trial is testingRelative Bioavailability of Binimetinib 3 x 15 mg and 45 mg FormulationsWho this might be right forMelanomaBRAF V600 MutationUnresectable Melanoma+1 more Pierre Fabre Medicament 14